Cat.#: ACPP-1420
| Despition | MOG |
| SIZE | 5 mg |
| Sequence | H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH. |
| Purity | > 97.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
| ACPP-1685 | Human MOG Protein (AC1685) | 10 µg | inquiry |
| ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
| ACPP-1495 | Cofilin Blocking Peptide (AC1495) | 250 µg | inquiry |
| ACPP-1391 | Human Apo D Protein (AC1391) | 2 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1162 | Recombinant Human GDNF Protein (Fc Tag) (AC1162) | 50 µg | inquiry |
| ACPP-1789 | Human PEDF Protein (AC1789) | 5 µg | inquiry |
| ACPP-1541 | Human OTOR Protein (AC1541) | 5 µg | inquiry |
| ACPP-1564 | Human EIF3K Protein (AC1564) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.